arrow
O

Olivier Huillard

institut du cancer paris carpem
H指数:27
被引数:3,192

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

P285 - ECE_2115 - Genomic characterization of aggressiveness in pituitary neuroendocrine tumors (PitNETs)

P285 - ECE_2115 - 垂体神经内分泌肿瘤(PitNETs)侵袭性的基因组特征

2026-08-100
OAAI
Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study

真实世界中免疫检查点阻断疗法在具有组织学变异亚型的晚期尿路上皮癌中的有效性和安全性:Pembroblad研究

2026-05-240
OA
Genomic characterization of aggressiveness in pituitary neuroendocrine tumors (PitNETs)

垂体神经内分泌肿瘤(PitNETs)中侵袭性的基因组特征

2026-04-070
OA
Resting energy expenditure as a predictor of immune checkpoint inhibitors response in older patients with non-small cell metastatic lung cancer: A pooled analysis of two prospective cohort studies

静息能量消耗作为预测老年非小细胞转移性肺癌患者免疫检查点抑制剂反应的指标:两项前瞻性队列研究的合并分析

2026-03-230
PRE
Real-World Outcomes of First-Line Immune-Based Combination Therapies in Bone-Metastatic Clear Cell Renal Cell Carcinoma

骨转移性透明细胞肾细胞癌中一线免疫为基础的联合疗法真实世界结局

2026-02-011
OA
Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
2026-01-200
PRE
Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Jimenez C, Andreassen M, Durand A, Moog S, Hendifar A, Welin S, 等人. LITESPARK-015 研究者团队. 贝zutifan治疗晚期嗜铬细胞瘤或副神经节瘤。新英格兰医学杂志。(2025)。doi: 10.1056/NEJMoa2504964

2025-10-014
PRE
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial

在多中心、随机CABASTY试验中,老年转移性去势抵抗性前列腺癌患者采用每两周 versus 每三周卡巴他赛方案时的疼痛与健康状况相关生活质量。

2025-02-010
OAAI
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients
2024-03-260
PRE
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
2024-01-251
PRE
Durvalumab (D) plus /- tremelimumab (T) in combination with dose-dense MVAC (ddMVAC) as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma (MIBC): Results of NEMIO, a randomized phase I-II trial
2023-10-013
OA
Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors

肌少症指标对接受PD-1免疫检查点抑制剂治疗的转移性非小细胞肺癌患者生存及严重免疫急性毒性的影响

2023-06-0110
OAAI
Positive Correlation Between 18F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas

肾上腺皮质癌中18F-FDG摄取与肿瘤增殖抗原Ki-67表达的正相关

2023-02-0811
PRE
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
2022-10-1726
OA